查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835417

全球退伍军人菌检测市场预测（2025-2032 年），按检测方法、产品类型、应用、最终用户和分销管道划分

Legionella Testing Market by Test Method, Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年退伍军人菌检测市场规模将成长至 7.8264 亿美元，复合年增长率为 9.24%。

主要市场统计数据
基准年2024年 3.8586亿美元
预计2025年 4.2231亿美元
预测年份：2032年 7.8264亿美元
复合年增长率（%） 9.24%

本执行摘要概述了塑造退伍军人菌侦测和控制格局的关键发展。儘管公共卫生官员和设施管理人员长期以来一直将退伍军人菌监测放在首位，但近期的技术进步、监管审查的加强以及不断变化的业务需求正在共同重塑组织检测和降低风险的方式。实验室科学、设施营运、水务公司和商业房地产领域的相关人员越来越需要切实可行的情报，以弥合实验室绩效与现场实施之间的差距。

下面，我们将提炼出方法论、供应链动态、监管压力点和最终用户期望方面最显着的变化。我们重点关注关税调整的影响，探讨测试方法、产品类型、应用、最终用户和分销管道之间的细分差异，并提供区域观点以指导策略规划。自始至终，我们专注于将测试数据转化为强大的管理方案，增强采购弹性，并利用创新来加快成果落地速度，增强决策信心。

本介绍作为后续章节的框架，提供分析深度和实用建议，旨在为领导者提供丰富的背景观点，以帮助做出投资决策、供应商参与以及实验室和现场工作流程的改进。

诊断技术的快速进步、法规的不断加强以及供应链的不断发展如何重塑实验室实践、采购和营运整合

过去几年发生了一系列变革性变化，重新定义了退伍军人菌检测的构想、实施和操作方式。分子诊断和生物感测器平台的技术进步缩短了获得结果的时间，并将检测从集中式实验室扩展到灵活的现场检测模式。同时，样品浓度、自动化系统和试剂品质的改进提高了可重复性，减少了人工差异，并使监测项目更加一致。

许多司法管辖区的法律规范正在收紧，提高了对文件记录、标准化验证和可追溯性的期望。这些监管收紧措施与相关人员对水资源管理透明度日益增长的需求相吻合，迫使设施管理人员和水务公司将测试结果整合到楼宇自动化和风险管理仪錶板中。同时，供应链日益复杂，以及诸如承包监控订阅和第三方实验室合作等新型服务模式的出现，正在改变采购行为和供应商关係。

综上所述，这些变化正在创造一个新格局：速度、可靠性和互通性与分析灵敏度同等重要。领导者若能将新技术投资与完善的检验方案和清晰的营运路径结合，将更有能力将诊断技术的进步转化为辐射暴露风险的显着降低。

2025 年关税变化如何改变整个退伍军人菌检测生态系统的供应链、筹资策略和成本管理方法

美国将在2025年实施的关税将对整个军团退伍军人菌检测生态系统产生复杂的连锁反应，影响製造商、经销商、检测实验室和最终用户。对于依赖全球采购精密零件的仪器製造商而言，进口成本的上升促使他们重新评估供应链策略，包括迁移组装组装、实现供应商多元化以及以模组化为重点的重新设计，以减轻关税的影响。这些策略调整将影响交货前置作业时间、产品供应以及实验室管理人员和设施营运商的长期资本规划。

试剂和耗材通常是检测项目的经常性支出，尤其容易受到成本变动的影响。因此，实验室经理和采购团队正在审查库存政策，评估替代试剂的化学成分，并协商长期供应协议以稳定单位成本。同时，服务供应商和合约实验室也面临决策：是自行承担成本、将成本转嫁给客户，还是优化工作流程以在维持交付和品质标准的同时保护净利率。

重要的是，关税压力正在加速两大应对措施。首先，企业重新重视国内生产和本地供应商开发，以减少跨国政策波动带来的影响。其次，企业越来越重视供应商的透明度和韧性，并将其作为采购标准，优先考虑能够提供试剂批次间等效性检验、本地技术支援以及零件短缺紧急时应对计画等服务的合作伙伴。这些转变正在重塑竞争动态，并使负责退伍军人菌监测的营业单位的采购决策变得更加复杂。

全面的细分观点，将分析方法、产品系列、应用程式、最终用户和分销管道与您的业务需求相结合

了解市场区隔对于设计满足营运需求和监管期望的测试策略至关重要。在考虑测试方法时，相关人员必须考虑生物感测器平台、培养方法、免疫测量和聚合酵素链锁反应) 等技术之间的权衡，每种技术都提供不同的操作特性。培养方法包括过滤过滤和传统琼脂培养，它们为样品处理和菌落计数提供不同的工作流程。 ELISA 和横向流动化验等免疫检测工具提供可用于高频监测的快速筛检功能。同时，聚合酵素链锁反应方法（包括即时PCR和传统 PCR）提供高度敏感的分子检测，对设备和解释的要求各不相同。生物感测器技术在现场监测中越来越受欢迎，其中速度和易用性是优先考虑的因素。

产品类型影响采购和实验室设计。设备选择范围广泛，从自动化系统到手动系统，自动化系统提供高通量和一致性，而手动系统则为小批量操作提供成本弹性。套件、试剂和耗材构成了日常检测活动的基础。主要试剂类别包括抗体、培养基和DNA聚合酵素，所有这些产品都必须符合严格的品质和批次间一致性标准。从第三方实验室分析到控制监控项目等服务，为那些倾向于外包技术执行并专注于纠正措施的营业单位提供了替代途径。

退伍军人菌检测应用因具体情况而异，但通常分为环境监测、设施管理和水处理三类。每种应用都有其独特的样本矩阵、结果用例和风险接受度，因此需要量身定制的方法来选择和验证策略。最终用户包括商业建筑、医院、研究机构和水务公司，每个用户都有其独特的营运限制、合规义务和相关人员期望。分销管道的选择——直销、分销商或线上——决定了产品和支援服务的获取途径，从而影响前置作业时间、技术服务可用性和采购复杂性。整合这些细分维度可以实现有针对性的采购、优化工作流程，并更好地将分析能力与现场风险缓解措施结合。

区域动态和监管差异影响全球市场中退伍军人菌监测计画的技术采用、服务模式和扩充性

区域动态对侦测专案的建构方式、技术的优先顺序以及服务模式的演变有重大影响。在美洲，监管重点和公司治理标准正在推动对检验的敏捷方法、整合资料平台以及可跨多站点产品组合扩展的服务伙伴关係关係的需求。该地区的市场参与企业通常优先考虑与楼宇管理系统的互通性和集中式彙报，以支援企业范围内的风险监控。

欧洲、中东和非洲 欧洲、中东和非洲的监管和基础设施环境各不相同，导致各国采用模式各异。一些国家实施严格的水安全计划和规定的检测通讯协定，而其他国家则强调能力建设和咨询框架。这种多样性为技术提供者创造了机会，他们可以提供模组化解决方案，既适用于严格监管的医院环境，也适用于更广泛的市政供水系统。该地区也积极关注永续性和资源效率，这影响着采样策略和设备选择。

亚太地区的特点是基础设施快速发展，日益重视公共卫生韧性，并不断扩大实验室现代化的投资。该地区的营业单位和大型商业开发商越来越多地采用自动化系统和分子诊断技术，以满足日益严格的标准和客户期望。在所有地区，本地製造能力、监管合规性以及技术服务网路的可近性仍然是决定采用检测方法和扩大监测项目可行性的关键因素。

竞争动态的考量显示技术创新、品质系统和服务整合决定了市场定位和采用轨迹

退伍军人菌检测领域的竞争态势将由技术创新、服务差异化和供应链韧性共同塑造。大型製造商持续投资快速分子检测、自动化和整合分析技术，而专业供应商则专注于现场生物感测器和高度自动化的培养工作站等细分领域能力。检测开发商、仪器製造商和服务实验室之间的策略伙伴关係日益普遍，从而能够提供包含硬体、耗材、验证支援和资料管理的捆绑式服务。

此外，拥有强大品管系统和透明批次验证流程的公司能够赢得实验室主任和设施经理的信任。服务型公司凭藉着灵活的合约模式、託管监控程序以及为多站点客户快速扩展现场营运的能力脱颖而出。从商业性角度来看，将与通路合作伙伴的直接交易与数位商务结合的分销策略有助于加快部署速度并提供在地化支援。

围绕检测化学和生物感测器架构的智慧财产权持续影响着竞争定位，而对监管申报和现场检验研究的投资仍然是进入市场的重要障碍。那些将研发与实际用户需求相结合的公司，例如精简的工作流程、最低限度的培训要求以及清晰的解读指南，最有可能赢得中心化实验室和分散式设施团队的青睐。最终，市场会青睐那些集卓越技术、营运支援和弹性供应链于一体的公司。

实验室管理人员、采购团队和设施负责人可以实施的可行策略和营运措施，以提高测试效率和弹性

产业领导者应采取多管齐下的策略，在快速诊断投资与严格验证和采购弹性之间取得平衡。首先，优先进行验证研究，将检测效能与营运决策阈值直接关联，确保所选检测方法适用于设施中遇到的特定样本基质和用例场景。此外，应进行现场试验，以评估易用性、维护需求和下游资料整合要求，作为实验室验证的补充。

第二，将弹性标准纳入采购流程，加强供应商关係。强制要求试剂等效性、替代采购计划和本地技术支援的透明度。在可行的情况下，实现供应商组合多元化，以减少单一来源中断的风险，并评估长期合同，以应对政策变化导致的价格波动。第三，投资于员工能力和程序标准化，以确保将检测结果转化为纠正措施。训练计画、能力评估和清晰的升级路径可以减少解读的差异性，并缩短反应时间。

最后，将检测结果整合到更广泛的水安全和设施管理系统中，将数据与预防管治连结起来。建立明确的资料所有权治理机制、触发改进的阈值，以及纳入新科学证据和监管更新的定期审查流程。将技术严谨性与供应链前瞻性和营运整合相结合，可以帮助组织增强韧性，更有效地降低退伍军人菌暴露风险。

采用稳健的混合方法研究途径，结合相关人员访谈、实验室检验评审和供应链映射，提供可行的建议

基础研究采用混合方法，旨在捕捉技术性能属性和营运实际情况。主要研究包括对实验室主任、设施经理、营业单位代表和监管相关人员的结构化访谈，以收集关于方法偏好、采购限制和验证期望的定性见解。这些相关人员的观点辅以对实验室工作流程和现场采样通讯协定的观察性审查，以在实际实践中得出结论。

二次研究利用同行评审文献、监管指南文件和技术白皮书，绘製方法能力、性能特征和合规性驱动因素图谱。检验了实验室验证研究，以评估培养、免疫测量、分子和生物感测器方法的出结果时间、灵敏度和操作要求。供应链分析评估了组件采购路径、经销商网路和服务模式配置，以确定弹性因素和潜在瓶颈。

分析步骤包括技术性能摘要和供应链映射，以交叉验证定性研究结果，并将其摘要为可行的建议。在相关情况下，情境分析检验了采购中断和监管变化的影响，提供了策略选择，但并未进行数值预测。这种调查方法确保研究结果既反映了测试表现的科学性，也反映了在不同作战情况下实施的实际限制。

主要调查方法的综合，强调了方法的严谨性、采购的弹性和运营的整合如何将诊断转化为有效的暴露缓解。

总而言之，退伍军人菌检测生态系统正处于技术能力、监管期望和采购现实交汇的曲折点。分子诊断和生物感测器平台的进步提供了更快、更灵活的检测方案，但价值链依赖严格的验证、营运整合和可靠的供应链。与关税相关的变化凸显了供应商透明度和国内韧性的重要性，影响筹资策略，并促使各组织重新评估其库存和采购政策。

細項分析表明，分析方法的选择必须以目的为主导。基于培养的方法仍然是许多合规框架的核心，而免疫测量和生物感测器则提供快速筛检能力，PCR技术则提供适合特定调查场景的分子灵敏度。产品选择、应用环境、最终用户限制和分销管道进一步决定了可行性和有效性。地区动态加剧了复杂性，因此需要适应性的产品，以尊重监管多样性和技术能力。

对于希望加强退伍军人菌计画的领导者来说，未来的道路是严谨的调查方法、弹性采购、强大的员工队伍以及数据主导的管治的结合。透过使投资与业务需求保持一致，并强调检验等效性和供应商的连续性，组织可以将诊断方面的进步转化为持续降低暴露风险并改善公共卫生结果。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 扩展远端物联网水质监测系统，用于大型设施中的退伍军人菌即时检测
  • 引入数位 PCR 检测以提高退伍军人菌检测实验室的灵敏度和速度
  • 整合人工智慧驱动的预测分析，主动评估建筑水系统中退伍军人菌的风险
  • 根据最新的国际水安全指南，对退伍军人菌进行强制性常规检测的监管执行
  • 开发携带式快速免疫检测装置，用于现场退伍军人菌筛检，以减少对实验室的依赖
  • 实施集中式资料平台，用于跨多个站点的退伍军人菌检测结果，以便更轻鬆地追踪合规性
  • 水处理公司和检测实验室合作伙伴提供端到端退伍军人菌管理解决方案

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章退伍军人菌检测市场（依检测方法）

  • 生物感测器
  • 培养方法
    • 薄膜过滤培养
    • 常规琼脂培养
  • 免疫检测
    • ELISA方法
    • 横向流动化验
  • PCR方法
    • 即时PCR
    • 常规PCR方法

第九章退伍军人菌检测市场（依产品类型）

  • 装置
    • 自动化系统
    • 手动系统
  • 套件
  • 试剂和耗材
    • 抗体
    • 培养基
    • DNA聚合酵素
  • 服务

第十章退伍军人菌检测市场（依应用）

  • 环境监测
  • 设施管理
  • 水处理

第 11 章退伍军人菌检测市场（依最终用户）

  • 商业大厦
  • 医院
  • 研究所
  • 供水业务

第 12 章退伍军人菌检测市场（依通路）

  • 直销
  • 经销商
  • 在线的

第十三章退伍军人菌检测市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章退伍军人菌检测市场：依类别

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按国家/地区分類的退伍军人菌检测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Eurofins Scientific SE
    • SGS SA
    • ALS Limited
    • Intertek Group plc
    • Bureau Veritas SA
    • TUV SUD AG
    • NSF International
    • Underwriters Laboratories LLC
    • Pace Analytical Services, LLC
    • Charles River Laboratories International, Inc.
Product Code: MRR-43470FC6086E

The Legionella Testing Market is projected to grow by USD 782.64 million at a CAGR of 9.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 385.86 million
Estimated Year [2025] USD 422.31 million
Forecast Year [2032] USD 782.64 million
CAGR (%) 9.24%

This executive summary synthesizes the critical developments shaping the landscape of Legionella testing and control. While public health authorities and facility managers have long prioritized Legionella surveillance, recent technological advances, heightened regulatory scrutiny, and evolving operational demands are converging to reshape how organizations detect and mitigate risk. Stakeholders across laboratory science, facility operations, water utilities, and commercial real estate increasingly require actionable intelligence that bridges laboratory performance with on-the-ground implementation.

The narrative that follows distills the most salient shifts in methodologies, supply chain dynamics, regulatory pressure points, and end-user expectations. It highlights the implications of tariff adjustments, examines segmentation nuances across test methods, product types, applications, end users, and distribution channels, and provides regional perspectives to inform strategic planning. Throughout, emphasis is placed on operationalizing test data into robust control programs, strengthening procurement resilience, and leveraging innovation to reduce time-to-result and enhance confidence in decision-making.

This introduction frames the subsequent sections, which collectively deliver both analytic depth and pragmatic recommendations. The intent is to equip leaders with context-rich perspectives that support investment decisions, supplier engagement, and improvements to laboratory and field workflows.

How rapid diagnostic advances, regulatory tightening, and supply chain evolution are collectively reshaping testing practices, procurement, and operational integration

The past several years have witnessed a set of transformative shifts that are redefining how Legionella testing is conceived, executed, and translated into action. Technological progress in molecular diagnostics and biosensor platforms has compressed time-to-result and expanded the locus of testing beyond centralized laboratories into field-adaptable formats. Concurrently, improvements in sample concentration, automated systems, and reagent quality are enhancing reproducibility and reducing manual variability, enabling more consistent surveillance programs.

Regulatory frameworks are tightening in many jurisdictions, prompting greater documentation, standardized validation, and expectations for traceability. This regulatory tightening operates alongside growing stakeholder demand for transparency in water management, driving facility managers and water utilities to integrate testing outputs with building automation and risk management dashboards. At the same time, supply chain complexity and the emergence of novel service models, such as turnkey monitoring subscriptions and third-party laboratory partnerships, are altering procurement behavior and vendor relationships.

Taken together, these shifts are creating a landscape where speed, reliability, and interoperability matter as much as analytical sensitivity. Leaders who align investments in new technology with robust validation protocols and clear operational pathways will be better positioned to convert diagnostic advances into measurable reductions in exposure risk.

Assessment of how tariff changes in 2025 have altered supply chains, procurement strategies, and cost-management approaches across the Legionella testing ecosystem

The introduction of tariffs in the United States during 2025 has generated a complex ripple effect across the Legionella testing ecosystem, affecting manufacturers, distributors, laboratories, and end users. For equipment makers that rely on global sourcing for precision components, increased import costs have incentivized a reassessment of supply chain strategies, including relocation of assembly, diversification of suppliers, and redesigns that emphasize modularity to mitigate tariff exposure. These strategic adjustments carry implications for lead times, product availability, and long-term capital planning for laboratory managers and facility operators.

Reagents and consumables, which often represent recurring expenditure for testing programs, are particularly sensitive to cost shifts. Laboratory directors and procurement teams are therefore reassessing inventory policies, evaluating alternative reagent chemistries, and negotiating longer-term supply agreements to stabilize unit costs. In parallel, service providers and contract laboratories face decisions about absorbing costs, passing them through to clients, or optimizing workflows to preserve margins while maintaining turnaround times and quality standards.

Importantly, tariff-induced pressures are accelerating two broader responses. First, there is a renewed emphasis on domestic manufacturing and local supplier development to reduce exposure to cross-border policy volatility. Second, organizations are increasingly valuing supplier transparency and resilience as procurement criteria, prioritizing partners that can offer validated equivalence across reagent lots, local technical support, and contingency plans for component shortages. These shifts are reshaping competitive dynamics and complicating procurement decisions for entities responsible for Legionella surveillance.

Comprehensive segmentation perspectives that align analytical methods, product portfolios, applications, end users, and distribution pathways with operational needs

Understanding market segmentation is central to designing testing strategies that match operational needs and regulatory expectations. When considering test methods, stakeholders must weigh trade-offs among biosensor platforms, culture methods, immunoassays, and polymerase chain reaction techniques, each offering distinct operational profiles. Culture methods remain foundational for regulatory compliance in many contexts and include both membrane filtration culture and traditional agar culture approaches that differ in sample processing and colony enumeration workflows. Immunoassay tools such as ELISA and lateral flow assays offer rapid screening capabilities that can be useful for high-frequency monitoring, whereas polymerase chain reaction approaches, which encompass real-time PCR and traditional PCR, provide sensitive molecular detection with varying requirements for instrumentation and interpretation. Biosensor technologies are gaining traction for on-site monitoring where speed and ease of use are prioritized.

Product type influences procurement and laboratory design. Equipment choices span automated and manual systems, with automation delivering throughput and consistency while manual systems provide cost flexibility for low-volume operations. Kits, reagents, and consumables form the backbone of daily testing activity; key reagent categories include antibodies, culture media, and DNA polymerases, all of which must meet rigorous quality and lot-to-lot consistency standards. Services-ranging from third-party laboratory analysis to managed monitoring programs-offer alternative pathways for entities that prefer to outsource technical execution and focus on corrective actions.

Applications for Legionella testing vary by context and are commonly grouped into environmental monitoring, facility management, and water treatment. Each application carries unique sample matrices, result-use cases, and risk tolerances, necessitating method selection and validation strategies tailored to the specific purpose. End users include commercial buildings, hospitals, research institutes, and water utilities, with each category presenting distinctive operational constraints, compliance obligations, and stakeholder expectations. Distribution channel choices-direct sales, distributors, and online-shape access to products and support services, affecting lead times, technical service availability, and procurement complexity. Integrating these segmentation dimensions enables targeted procurement, optimized workflows, and stronger alignment between analytical capability and on-site risk mitigation.

Regional dynamics and regulatory variations that influence technology adoption, service models, and the scalability of Legionella monitoring programs across global markets

Regional dynamics exert a strong influence on how testing programs are structured, which technologies are prioritized, and how service models evolve. In the Americas, regulatory attention and corporate governance standards are driving demand for validated rapid methods, integrated data platforms, and service partnerships that can scale across multi-site portfolios. Market participants in this region often emphasize interoperability with building management systems and centralized reporting to support enterprise-wide risk oversight.

Europe, the Middle East & Africa present a heterogeneous regulatory and infrastructural environment where adoption patterns vary across jurisdictions. Some countries implement stringent water safety plans and prescriptive testing protocols, while others emphasize capacity building and advisory frameworks. This diversity creates opportunities for technology providers that can offer modular solutions adaptable to both highly regulated hospital settings and broader municipal water systems. The region also demonstrates active interest in sustainability and resource efficiency, which influences sampling strategies and equipment selection.

Asia-Pacific features rapid infrastructure development, a rising focus on public health resilience, and growing investment in laboratory modernization. Water utilities and large commercial developers in the region are increasingly adopting automated systems and molecular diagnostics to meet tightening standards and customer expectations. Across all regions, local manufacturing capability, regulatory alignment, and access to technical service networks remain critical determinants of method adoption and the feasibility of scaling monitoring programs.

Insights into competitive dynamics showing how innovation, quality systems, and service integration determine market positioning and adoption trajectories

Competitive dynamics in the Legionella testing space are shaped by a combination of technological innovation, service differentiation, and supply chain resilience. Leading manufacturers continue to invest in rapid molecular assays, automation, and integrated analytics, while specialized providers focus on niche capabilities such as on-site biosensors or highly automated culture workstations. Strategic partnerships between assay developers, instrument manufacturers, and service laboratories are increasingly common, enabling bundled offerings that combine hardware, consumables, validation support, and data management.

Moreover, companies that demonstrate robust quality management systems and transparent lot validation processes gain trust among laboratory directors and facility managers. Service-oriented firms differentiate through flexible contracting models, managed monitoring programs, and the ability to rapidly scale field operations for multi-site clients. From a commercial perspective, distribution strategies that combine direct engagement with channel partners and digital commerce facilitate faster deployment and localized support.

Intellectual property around assay chemistries and biosensor architectures continues to influence competitive positioning, and investments in regulatory submissions and field validation studies remain key barriers to entry. Firms that align R&D with pragmatic user needs-streamlined workflows, minimal training requirements, and clear interpretive guidance-are best positioned to win adoption among both centralized laboratories and decentralized facility teams. Ultimately, the market rewards combinations of technical excellence, operational support, and resilient supply chains.

Actionable strategic and operational measures that laboratory managers, procurement teams, and facility leaders can implement to enhance testing effectiveness and resilience

Industry leaders should adopt a multi-pronged strategy that balances investment in rapid diagnostics with rigorous validation and procurement resilience. First, prioritize validation studies that directly map test performance to operational decision thresholds, ensuring that chosen methods are fit-for-purpose across the specific sample matrices and use-case scenarios encountered in your facilities. Complement laboratory validation with field pilots that assess ease of use, maintenance demands, and downstream data integration requirements.

Second, strengthen supplier relationships by incorporating resilience criteria into procurement processes. Require transparency on reagent equivalence, alternate sourcing plans, and local technical support. Where feasible, diversify supplier portfolios to reduce exposure to single-source disruptions and evaluate long-term contracting to manage price volatility associated with policy shifts. Third, invest in workforce capability and procedural standardization so that test outputs reliably translate into corrective actions. Training programs, competency assessments, and clear escalation pathways will reduce interpretation variability and improve response times.

Finally, integrate testing outputs into broader water safety and facility management systems to turn data into preventive measures. Establish clear governance for data ownership, thresholds that trigger remediation, and periodic review processes that incorporate new scientific evidence and regulatory updates. By combining technical rigor with supply chain foresight and operational integration, organizations can enhance resilience and more effectively mitigate Legionella exposure risk.

Robust mixed-methods research approach combining stakeholder interviews, laboratory validation reviews, and supply chain mapping to inform pragmatic recommendations

The underlying research employs a mixed-methods approach designed to capture both technical performance attributes and operational realities. Primary research included structured interviews with laboratory directors, facility managers, water utility representatives, and regulatory stakeholders to gather qualitative insights on method preferences, procurement constraints, and validation expectations. These stakeholder perspectives were supplemented by observational reviews of laboratory workflows and field sampling protocols to ground conclusions in real-world practices.

Secondary research drew on peer-reviewed literature, regulatory guidance documents, and technical white papers to map method capabilities, performance characteristics, and compliance drivers. Laboratory verification studies were reviewed to evaluate comparative time-to-result, sensitivity, and operational requirements across culture, immunoassay, molecular, and biosensor approaches. Supply chain analyses assessed component sourcing pathways, distributor networks, and service model configurations to identify resilience factors and potential bottlenecks.

Analytic steps included cross-validation of qualitative findings with technical performance summaries and supply chain mapping, followed by synthesis into actionable recommendations. Where relevant, scenario analyses explored implications of procurement disruptions and regulatory shifts to inform strategic options without producing numeric forecasts. This methodology ensures that the findings reflect both the scientific realities of assay performance and the pragmatic constraints of implementation in diverse operational contexts.

Synthesis of key findings emphasizing how methodological rigor, procurement resilience, and operational integration translate diagnostics into effective exposure mitigation

In sum, the Legionella testing ecosystem is at an inflection point where technological capability, regulatory expectations, and procurement realities intersect. Advances in molecular diagnostics and biosensor platforms are delivering faster and more flexible options for detection, but their value hinges on rigorous validation, operational integration, and reliable supply chains. Tariff-related shifts have underscored the importance of supplier transparency and domestic resilience, influencing procurement strategies and prompting organizations to reassess inventory and sourcing policies.

Segmentation analysis clarifies that method selection must be purpose-driven: culture-based approaches remain central to many compliance frameworks, immunoassays and biosensors provide rapid screening capacity, and PCR techniques offer molecular sensitivity suited to specific investigative scenarios. Product choices, application contexts, end-user constraints, and distribution channels further determine feasibility and effectiveness. Region-specific dynamics add another layer of complexity, requiring adaptable offerings that respect regulatory diversity and technical capacity.

For leaders seeking to strengthen their Legionella programs, the path forward combines methodological rigor, resilient procurement, workforce capability, and data-driven governance. By aligning investments with operational needs and emphasizing validated equivalence and supplier continuity, organizations can translate diagnostic advances into sustained reductions in exposure risk and improved public health outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of remote IoT-enabled water monitoring systems for real-time Legionella detection in large facilities
  • 5.2. Adoption of digital PCR testing methods to improve sensitivity and speed in Legionella detection laboratories
  • 5.3. Integration of AI-driven predictive analytics for proactive Legionella risk assessment in building water systems
  • 5.4. Regulatory enforcement of mandatory routine Legionella testing under updated international water safety guidelines
  • 5.5. Development of portable rapid immunoassay devices for on-site Legionella screening to reduce laboratory dependence
  • 5.6. Implementation of centralized data platforms for multi-site Legionella testing results to facilitate compliance tracking
  • 5.7. Collaboration between water treatment firms and testing labs to deliver end-to-end Legionella management solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Legionella Testing Market, by Test Method

  • 8.1. Biosensor
  • 8.2. Culture Method
    • 8.2.1. Membrane Filtration Culture
    • 8.2.2. Traditional Agar Culture
  • 8.3. Immunoassay
    • 8.3.1. Elisa
    • 8.3.2. Lateral Flow Assay
  • 8.4. Polymerase Chain Reaction
    • 8.4.1. Real-Time PCR
    • 8.4.2. Traditional PCR

9. Legionella Testing Market, by Product Type

  • 9.1. Equipment
    • 9.1.1. Automated Systems
    • 9.1.2. Manual Systems
  • 9.2. Kits
  • 9.3. Reagents And Consumables
    • 9.3.1. Antibodies
    • 9.3.2. Culture Media
    • 9.3.3. Dna Polymerases
  • 9.4. Services

10. Legionella Testing Market, by Application

  • 10.1. Environmental Monitoring
  • 10.2. Facility Management
  • 10.3. Water Treatment

11. Legionella Testing Market, by End User

  • 11.1. Commercial Buildings
  • 11.2. Hospitals
  • 11.3. Research Institutes
  • 11.4. Water Utilities

12. Legionella Testing Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Legionella Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Legionella Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Legionella Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Eurofins Scientific SE
    • 16.3.2. SGS SA
    • 16.3.3. ALS Limited
    • 16.3.4. Intertek Group plc
    • 16.3.5. Bureau Veritas SA
    • 16.3.6. TUV SUD AG
    • 16.3.7. NSF International
    • 16.3.8. Underwriters Laboratories LLC
    • 16.3.9. Pace Analytical Services, LLC
    • 16.3.10. Charles River Laboratories International, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. LEGIONELLA TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LEGIONELLA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST LEGIONELLA TE